136 0

Single chain variable fragment CD7 antibody conjugated PLGA/HDAC inhibitor immuno-nanoparticles: Developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV

Title
Single chain variable fragment CD7 antibody conjugated PLGA/HDAC inhibitor immuno-nanoparticles: Developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV
Other Titles
HDAC inhibitor immuno-nanoparticles: Developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV
Author
이근용
Keywords
Latency virus; HIV; HDAC inhibitor; PLGA; scFvCD7; Immuno-nanoparticle
Issue Date
2011-11
Publisher
ELSEVIER SCIENCE BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
Citation
Journal of Controlled Release. Nov 2011, 152, e9-e10
Abstract
ABSTRACT SUMMARY: Latent HIV can be activated through inhibition of histone deacetylase using HDAC inhibitors (HDACi). Pleiotropic effects of HDAC include reactivation of other latent viruses. To minimize such risks, we have developed a novel PLGA immuno-nanoparticle for delivering HDACi exclusively to human T cells, the major reservoirs for latent HIV, using a single chain fragment antibody targeting the CD7 molecule on T cells. The immuno-nanoparticle successfully activated latent HIV in the human T cell line ACH2 and could deliver cargo to primary human T cells. This approach opens avenues for the eradication of HIV when used with HAART through elimination of HIV reservoirs.
URI
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&CSC=Y&NEWS=N&SEARCH=00078447-201111301-00006.anhttp://hdl.handle.net/20.500.11754/36980
ISSN
0168-3659
DOI
10.1016/j.jconrel.2011.08.089
Appears in Collections:
COLLEGE OF ENGINEERING[S](공과대학) > BIOENGINEERING(생명공학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE